Abstract
We examined different fluorescent probes suitable for fluorometric determination of α1-acid glycoprotein (AGP) in serum. Quinaldine red (QR) was shown to bind strongly and selectively to AGP. Taking advantage of the enhanced fluorescence of QR in the presence of AGP, we developed a direct method for the determination of serum AGP without removal of other serum proteins such as albumin. AGP concentrations in serum of healthy volunteers and patients correlated well with results from the conventional single radial immunodiffusion (SRID) method (r = 0.93, slope = 1). The newly developed method is faster and has a larger analytical concentration range than the SRID method. This method can also be used to determine AGP in serum of experimental animals, and it can serve to monitor AGP serum concentrations for pharmacokinetic evaluation of basic drugs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
S. Pervaiz and K. Brew. Homology and structure-function correlations between α1-acid glycoprotein and serum retinol-binding protein and its relatives. FASEB J 1:209–214 (1988).
F. M. Belapaire, M. G. Bogaert, and M. Rosseneu. Binding of β-adrenoreceptor blocking drugs to human serum albumin, to α1-acid glycoprotein, and to human serum. Eur. J. Clin. Pharmacol. 22:253–256 (1982).
K. J. Julius and W. Ulrich. Steroid-protein interaction; Complex formation between α1-acid glycoprotein and steroid hormones. Biochim. Biophys. Acta 170:324–333 (1968).
D. A. Cheresh, D. H. Haynes, and J. A. Distasio. Interaction of an acute phase reactant, α1-acid glycoprotein (orosomucoid), with the lymphoid cell membrane: A model for non-specific immune suppression. Immunology 51:541–548 (1984).
J. M. H. Kremer, J. Wilting, and L. H. M. Janssen. Drug binding to human α1-acid glycoprotein in health and disease. Pharmacol. Rev. 40:1–47 (1988).
P. A. Fred, J. Jean, and O. Yechiam. Effects of cancer and its treatments on plasma concentration of α1-acid glycoprotein and propranolol binding. Clin. Pharmacol. Ther. 32:659–663 (1982).
M. J. Kendall, C. P. Quarterman, H. Bishop, and R. E. Schneider. Effects of inflammatory disease on plasma oxprenolol concentrations. Br. Med. J. 2:465–468 (1979).
K. A. Won and H. Baumann. NF-AB, a liver-specific and cytokine-inducible nuclear factor that interacts with the interleukin-1 response element of the rat α1-acid glycoprotein gene. Mol. Cell. Biol. 11:3001–3008 (1991).
Y. Sugiyama, Y. Suzuki, Y. Sawada, S. Kawasaki, T. Beppu, T. Iga, and M. Hanano. Auramin O as a fluorescent probe for the binding of basic drugs to human α1-acid glycoprotein. Biochem. Pharmacol. 34:821–829 (1985).
H. Imamura, T. Maruyama, and M. Otagiri. Evaluation of quinaldine red as a fluorescent probe for studies of drug-α1-acid glycoprotein interaction. Bio. Pharm. Bull. 16:926–929 (1993).
G. Scatchard. Attractions of proteins for small molecules and ions. Ann. N.Y. Acad. Sci. 51:660–672 (1949).
P. A. Routledge, A. Barchowsky, T. D. Biornsson, B. B. Kitchell, and D. G. Shand. Lidocaine plasma protein binding. Clin. Pharmacol. Ther. 27:347–351 (1980).
D. Rudman, P. E. Treadwell, W. R. Vogler, C. H. Howard, and B. Hollins. An abnormal orosomucoid in the plasma of patients with neoplastic disease. Cancer Res. 32:1951–1959 (1972).
J. E. S. Hansen, V. A. Larsen, and T. C. Boeg-Hansen. The microheterogeneity of α1-acid glycoprotein in inflammatory lung disease, cancer of the lung, and normal health. Clin. Chim. Acta 138:41–47 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Imamura, H., Maruyama, T., Okabe, H. et al. A Simple and Rapid Fluorometric Determination Method of α1-Acid Glycoprotein in Serum Using Quinaldine Red. Pharm Res 11, 566–570 (1994). https://doi.org/10.1023/A:1018926902083
Issue Date:
DOI: https://doi.org/10.1023/A:1018926902083